![Figure 3 | A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life | SpringerLink Figure 3 | A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs00520-018-4599-x/MediaObjects/520_2018_4599_Fig3_HTML.png)
Figure 3 | A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life | SpringerLink
Supplementary Table 6. Dose changes during the 1-year observa- tion period Discontinuation group Continuation group Total Dose
![Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine](https://www.thelancet.com/cms/attachment/d763732d-acff-446e-872e-e81d6e44f06f/gr1_lrg.jpg)
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine
Page 1 SUPPLEMENTARY MATERIALS The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotr
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing | PLOS Pathogens
![Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known? | Semantic Scholar Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4ec23ddbac7d81fb262ff5eda3cfed0d64d3ab2e/3-Table1-1.png)
Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known? | Semantic Scholar
![Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis | Scientific Reports Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep09599/MediaObjects/41598_2015_Article_BFsrep09599_Fig1_HTML.jpg)
Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis | Scientific Reports
Supplementary table 4 Association between the dose or running and the risk of all-cause mortality: meta-regression estimates for
SUPPLEMENTARY MATERIALS Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cys
![Monica Gandhi MD, MPH on Twitter: "So, yes, the assessment of asymptomatic infection could occur before the 2nd dose, right? Meaning, were there FEWER asymptomatic infections in those who got the vaccine Monica Gandhi MD, MPH on Twitter: "So, yes, the assessment of asymptomatic infection could occur before the 2nd dose, right? Meaning, were there FEWER asymptomatic infections in those who got the vaccine](https://pbs.twimg.com/media/ErfML22VkAI21dh.jpg)
Monica Gandhi MD, MPH on Twitter: "So, yes, the assessment of asymptomatic infection could occur before the 2nd dose, right? Meaning, were there FEWER asymptomatic infections in those who got the vaccine
![Subject flow through the study. See Supplementary Table 1 for details... | Download Scientific Diagram Subject flow through the study. See Supplementary Table 1 for details... | Download Scientific Diagram](https://www.researchgate.net/publication/265055536/figure/fig1/AS:269877143404553@1441355133343/Subject-flow-through-the-study-See-Supplementary-Table-1-for-details-of-the-reasons-why.png)
Subject flow through the study. See Supplementary Table 1 for details... | Download Scientific Diagram
SUPPLEMENTARY DATA Supplementary Table 1. Model assumptions for the assignment of treatments and estimated therapeutic and behav
![Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. - Abstract - Europe PMC Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3689226/bin/clpt20132t3.jpg)
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. - Abstract - Europe PMC
Supplementary Table 4. Final doses of donepezil administered in the patients who discontinued and continued treatment during the
![Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01632-2/MediaObjects/41416_2021_1632_Fig1_HTML.png)